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Aim: The present study evaluated the capacity of three species of Fusarium isolated from onychomycosis
to form biofilms and the antibiofilm effect of propolis extract on these biofilms.Materials & methods: The
biofilms and antibiofilm effects were evaluated by quantifying the colony-forming units, mitochondrial
metabolic activity assays, total biomass by crystal violet staining and scanning electronmicroscopy. Results:
Propolis extract demonstrated significant antibiofilm efficiency on Fusarium spp. isolates and reduced F.
solani, F. oxysporum and F. subglutinansmature biofilms. Conclusion: Propolis extract can be an alternative
topical treatment of onychomycosis caused by Fusarium spp.
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Fusarium species are geophilic fungi, frequently isolated from opportunistic infections in immunocompromised
patients, causing disseminated infections with high rates of mortality [1]. Onychomycosis, a fungal infection caused
by Fusarium spp., can also affect immunocompetent patients [2]. It has previously been reported that paronychia,
a characteristic of onychomycosis caused by this fungus, can be an entry portal to disseminated infections [3].
Moreover, fusariosis has the highest incidence of infection among invasive fungal diseases in Brazil, with high
mortality in hematological patients [4].
While the pathogenesis of fusariosis is not completely understood, the virulence factors of these fungi appear
to be determinants for infection. Of these, biofilms are related to antifungal resistance and greater difficulty in
treatment [5]. Additionally, some studies have described the capacity of F. oxysporum to form biofilm in vitro [6] or
as an onychomycosis agent [7].
Studies focusing on finding new antifungal agents are urgently required, as there is a limited therapeutic arsenal
available for Fusarium spp. infections. Alternatives include natural products, especially as they are inexpensive and
have low toxicity. Propolis is a natural product collected from the hives of Apis mellifera L. Several studies have
described the medicinal properties of propolis, such as its anti-inflammatory and antitumor effects and antifungal
and antibacterial activity [8,9]. In the present study, biofilms formed by three species of Fusarium were characterized
and the activity of propolis extract (PE) against these biofilms was evaluated.
Materials & methods
Fusarium strains
Fungi were isolated from the nail samples of patients with onychomycosis. Nail scrapings were cultivated in three
tubes containing Sabouraud dextrose agar (SDA; Himedia Laboratories, Mumbai, India) and three tubes that
contained Mycosel medium (Himedia Laboratories, Mumbai, India). The identification of fungi was performed
using classic methods, including the examination of colonies andmicroscopic morphology [10,11]. The fungi isolated
and identified were maintained in a freeze-dried state in the Mycological Collection of the Laboratory of Medical
Mycology of the State University of Maringa´ (UEM), Brazil. One clinical isolate was randomly chosen from each of
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the three most frequent species of Fusarium in our region: F. oxysporum (FO42), F. solani (FS04) and F. subglutinans
(FSub39). We also used a reference strain of F. solani (ATCC 36031), kindly provided by Fiocruz (Oswaldo Cruz
Foundation, Brazil).
Biofilm formation
This assay was based on the methodology described by Silva et al. [12] with modifications. The strains of Fusarium
spp. were grown on potato dextrose agar (PDA; Himedia Laboratories, Mumbai, India) for 7 days at 25◦C. The
colonies were gently scraped, harvested in 0.85% sterile saline and the conidia were counted in a Neubauer chamber.
The inoculum was adjusted to a final concentration of 1 × 106 conidia ml-1 [13,14] on Sabouraud dextrose broth
medium (SDB; Himedia Laboratories), and 200 μl of this suspension was placed into 96-well plates. The plates
were then incubated without agitation at 37◦C for 2 h in order to settle and to adhere the conidia to the bottom of
the plate, and were then incubated at 37◦C in a shaker at 110 rev min-1. Every 24 h, 100 μl of SDB was removed
and an equal volume of fresh SDB without Fusarium was added to each well for renewal of the culture medium.
The plates were then incubated for 72 h. All experiments were repeated on three occasions with individual samples
evaluated in triplicate.
Biofilm biomass quantification by crystal violet staining
Biofilms were allowed to grow for 24, 48 and 72 h. They were then washed three-times with sterile saline and after
drying, 200 μl of methanol was added to each well for 15 min to affix the biofilms. Later, 200 μl of crystal violet
(1% v/v) was added for 5 min. The wells were washed with sterile distilled water and 200 μl of acetic acid (33%
v/v) was then added to dissolve the stain. The obtained solution was read in a microtiter plate reader at 570 nm
and the absorbance values were standardized per unit area of well (absorbance cm-2).
Biofilm metabolic activity assay by XTT reduction
The reduction assay of the tetrazolium salt 2,3-(2-methoxy-4-nitro-5-sulphophenyl)-5-([phenylamino]carbonyl)-
2H tetrazolium hydroxide (XTT; Sigma-Aldrich, MO, USA) was used to determine in situ biofilm mitochondrial
activity. After biofilm formation, each well was washed three-times with sterile saline. A total of 100 μl of a solution
containing XTT, phenazine methosulphate (PMS) and 0.85% sterile saline was added to each well: 60 μl of sterile
saline, then 20 μl of XTT stock solution (500 μg ml-1) and 20 μl of PMS stock solution (50 μg ml-1) were added.
The final concentrations of XTT and PMS in the wells were 100 and 10 μg ml-1, respectively. The plates were
then incubated at 35◦C for 3 h, protected from the light. After this period, the absorbance of the obtained solution
was read in a microtiter plate reader at 492 nm and the absorbance values were standardized per unit area of well
(absorbance cm-2).
Scanning electron microscopy
This assay was based on the methodology described by Silva et al. [12]. To examine the structure of biofilms by
scanning electron microscopy (SEM), biofilms were allowed to form in 24-well polystyrene microtiter plates as
described above for 72 h. The wells were washed with sterile saline and the biofilms were dehydrated with alcohol
(using 70% for 10 min, 80% for 10 min, 95% for 10 min and 100% ethanol for 20 min) and air dried. Prior to
observation, the bases of the wells were cut out and mounted onto aluminum stubs, sputter coated with gold and
observed with an S-360 scanning electron microscope (Leo, MA, USA).
Biofilm viability assay
Biofilms were formed for 24, 48 and 72 h and were washed three-times with sterile saline. Then, 200 μl of saline
was added to each well and the biofilms were vigorously scraped with a pipette, transferred to a conical tube and
vortexed for 1 min. Aliquots of 15 μl were placed in a plate containing Dichloran rose bengal chloramphenicol
agar (Merck, Darmstadt, Germany) and were incubated at 35◦C. Dichloran rose bengal chloramphenicol agar
is a selective medium for the isolation and enumeration of viable molds and restricts colony size, improving the
enumeration and detection of the molds. The number of colony-forming units was determined after 5 days of
incubation.
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PE & phenol content
The propolis source was as described by Capoci et al. [15], with green propolis collected from hives of A. mellifera in
Cianorte (Parana´, Brazil). The samples were triturated and stored at -20◦C until further analysis. PE was prepared
with a propolis/ethanol ratio of 30/70 (w/w) by turbo extraction, at 3500 rpm, three-times at 15 min with two
intervals of 5 min. PE was filtered through filter paper and adjusted to the initial weight with ethanol. The total
phenol content (TPC) of PE was evaluated by the Folin–Ciocalteau method [16]. PE was added to 6 ml of the
Folin–Ciocalteau and 6 ml of 20% Na2CO3 (Sigma-Aldrich). After 2 h, absorbance was determined by Shimadzu
UV-1650PC spectrophotometer (Tokyo, Japan) at a wavelength of 760 nm. A calibration curve with solutions
of gallic acid was used as a reference. TPC was expressed as a percentage of total phenolic substances in PE and
corresponded to a mean of six replicates.
Antifungal assay
In vitro antifungal susceptibility testing of planktonic cells was performed using a microdilution method adapted
from Capoci et al. [15] and the Clinical and Laboratory Standards Institute M38-A2 protocol [17] with serial dilution
of PE 34.17, 68.35, 136.71, 273.43, 546.87, 1093.75, 2187.5, 4375, 8750 and 17,500μg ml-1 of TPC expressed
in gallic acid in RPMI 1640 (Roswell Park Memorial Institute; Gibco, NY, USA) with l-glutamine (with sodium
bicarbonate) and 0.165 M 3-(N-morpholino) propanesulfonic acid (pH 7.2) as a buffer (Sigma-Aldrich). The
strains of Fusarium spp. were grown on potato dextrose agar for 7 days at 25◦C. The colonies were gently scraped
and harvested in 0.85% sterile saline solution. The number of conidia were counted in a Neubauer chamber and
the inoculum was adjusted to a final concentration of 5 × 104 conidia ml-1 in RPMI 1640. An aliquot of PE
(100 μl) was dispensed into 96-well plates and further incubated with aliquots (100 μl) of the Fusarium inoculum.
The 96-well plates were incubated at 35◦C for 72 h. The minimal inhibitory concentration (MIC) values were
determined by visualization, corresponding to the lowest concentration of antifungal agent in which no visible
growth was observed, in comparison with the control (cells grown without PE) [15,17]. The minimal fungicidal
concentration (MFC) was determined after 72 h of incubation at 35◦C and 5 μl of each well was transferred to a
plate containing sabouraud dextrose agar and incubated at 25◦C for 48 h.
Antibiofilm assay
Once stable andmature biofilms were formed (for 24 h as described above) they were washed three-times with sterile
saline. Biofilms were formed as described above for 24 h. Then, PE was added at the MFC concentration found in
the latter assay. The 96-well plates were incubated at 37◦C for a further 24 h. The activity of PE against biofilms was
determined by biomass quantification using crystal violet staining and by biofilm viability assay described above.
Epifluorescence microscopy
Antibiofilm assay was also evaluated by epifluorescence microscopy. Biofilms were formed in 24-well polystyrene
microtiter plates as described above for 24 h, then PE was added at the MFC concentration and the plates were
incubated at 37◦C for a further 24 h. The matrix of biofilms was then stained with calcofluor white (Fluka
Analytical, MO, USA) diluted in sterile saline (1:4) for 5 min and washed twice with sterile saline. Stained biofilms
were observed with a microscope (Evos FL, Live Technologies, CA, USA) with filters capable of detecting the fungi
cell wall (BP 365–370, FT 400, LP 421).
Statistical analysis
Data were analyzed using Prism 6.0 software (GraphPad, CA, USA). The t-test and one-way analysis of variance
with Bonferroni were used. All of the tests were performed with a confidence level of 95% and values of p ≤ 0.05
were considered statistically significant.
Results
The three species of Fusarium tested in this study formed biofilms. Nevertheless, the F. solani strains were more
efficient than the other species in relation to total biomass and the number of viable cells. Furthermore, the biomass
produced by both the clinical isolates and reference strain of this species was directly proportional to incubation
time (Figure 1). While the total biomass of biofilms formed by F. solani increased from 24 to 48 h and from 48
to 72 h of incubation, the total biomass of F. oxysporum and F. subglutinans biofilms increased only until 48 h
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Figure 1. Crystal violet staining of biofilm biomass of Fusarium solani (ATCC 36031 and FS04), Fusarium oxysporum
(FO42) and Fusarium subglutinans (FSub39) at different times of incubation. ANOVA with Bonferroni, *p < 0.05.
and apparently became stable after this period (Figure 1). However, these increases in biomass production were
significant only for strains of F. solani and F. subglutinans, and mainly from 24 to 72 h (Figure 1).
In contrast, the absorbance values from the XTT reduction assay, related to biofilm metabolic activity, decreased
with incubation time. The decrease in absorbance values was significant from 24 to 72 h for all the isolates (Figure 2).
The clinical isolate of F. solani also presented significantly more viable cells on the biofilm than the other species
at 48 and 72 h of incubation. Most isolates, except for F. oxysporum, exhibited a significant increase in viable cells
from 24 to 48 h and from 24 to 72 h (Figure 3). The number of viable cells and the quantity of biomass were
quite similar among species with 24 h of incubation, but after this period, they began to show differences among
themselves.
SEM analysis revealed that the morphologies of the biofilm structure formed by the three different Fusarium
species differed. It was observed that biofilms of F. solaniwere formed by narrow, smooth hyphae; and conidiophores
with monophiliades, as well as macroconidia, were found in the clinical isolate (FS04). The biofilm of F. oxysporum
was formed by smooth hyphae with larger lumen, while F. subglutinans exhibited crystal-encrusted hyphae. The
structure of biofilms examined by SEM is shown in Figure 4.
Regarding in vitro antifungal susceptibility testing, PE exhibited strong fungicidal activity against Fusarium spp.
isolates in planktonic cells. TheMIC50 (i.e., theMIC that inhibited 50% of the isolates tested) andMIC90 (i.e., the
MIC that inhibited 90% of the isolates tested) corresponded to 1093.75 μg ml-1 of TPC expressed in gallic acid
and was used to test the fungicide activity of PE against biofilms formed by Fusarium species. Furthermore, MIC
and MFC were coincident (1093.75 μg ml-1 of TPC expressed in gallic acid) for all species.
In the exposure of the biofilms to PE, it was observed that the biomass of those treated with PE was significantly
lower than control (Figure 5). Similarly, the number of viable cells also decreased significantly after exposure to PE
(Figure 6). These results were confirmed by epifluorescence microscopy, in which it was observed that the number
of cells of biofilms treated with PE decreased and were more disorganized and damaged than control, without PE
(Figure 7). These data demonstrated the antifungal activity of PE not only on planktonic cells but also on Fusarium
biofilms.
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Figure 2. Absorbance values of XTT reduction assay of the three clinical isolates from onychomycosis and a
reference strain (Fusarium solani ATCC 36031) biofilms at different times of incubation. ANOVA with Bonferroni,
*p < 0.05.
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Figure 3. Colony forming units from Fusarium solani (ATCC 36031 and FS04), Fusarium oxysporum (FO42) and
Fusarium subglutinans (FSub39) biofilms at different times of incubation. ANOVA with Bonferroni, *p < 0.05.
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Figure 4. Scanning electron microscopy of Fusarium solani ATCC 36031 (A, A’), Fusarium solani FS04 (B, B’), Fusarium
oxysporum FO42 (C, C’) and Fusarium subglutinans FSub39 (D, D’) biofilms with 72 h of incubation. First column
500× magnification (A, B, C, D), second column 3000× magnification (A’, B’, C’, D’).
Discussion
Onychomycosis caused by Fusarium spp. is frequent in Brazil and has been increasing in recent years [2,10]. Its
pathogenesis and treatment, however, have not yet been completely elucidated.
According to our previous study [2], onychomycosis caused by Fusarium spp. is characterized by painful lesions,
paronychia and inflammatory reaction. In addition, the primary skin lesions caused by Fusarium spp. have been
considered a portal of entry for disseminated infections caused by this fungus, especially in neutropenic and
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Figure 5. Crystal violet staining of biofilm biomass of Fusarium solani (ATCC 36031 and FS04), Fusarium oxysporum
(FO42) and Fusarium subglutinans (FSub39) exposed to propolis extract and control, without propolis extract.
t-test, *p < 0.05.
PE: Propolis extract.
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Figure 6. Colony forming units from Fusarium solani (ATCC 36031 and FS04), Fusarium oxysporum (FO42) and
Fusarium subglutinans (FSub39) biofilms exposed to propolis extract and control.
t-test, *p < 0.05.
PE: Propolis extract.
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Figure 7. Epifluorescence of Fusarium solani ATCC 36031 (A, A’), Fusarium solani FS04 (B, B’), Fusarium oxysporum
FO42 (C, C’) and Fusarium subglutinans FSub39 (D, D’). First column shows control without PE, 2000× magnification
(A, B, C, D), second column shows biofilms treated with PE, 2000× magnification (A’, B’, C’, D’).
PE: Propolis extract.
transplanted patients [3,18]. Although Fusarium spp. is considered a non-keratinolytic fungus, this genus is able
to cause onychomycosis with the ability to form biofilms. According to Gupta et al. [7], there is evidence that
in onychomycosis, the fungi may be arranged in biofilms in complex, sessile microbial communities attached
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to epithelial surfaces. The capacity of F. oxysporum to form biofilms on fragments of human nails has also been
documented [6].
It has recently been shown for the first time that Fusarium spp. can grow in vitro using human nails as a single
source of nutrient; and also that members from this genus have the ability to invade healthy human nails [10].
In the current study, the capacity of clinical isolates of F. solani, F. oxysporum and F. subglutinans obtained from
onychomycosis to form biofilms was demonstrated, a finding similar to those described by Costa-Orlandi et
al. (2014) [14] for the dermatophytes T. rubrum and T. mentagrophytes, which are the most common agents of
onychomycosis.
While all the species of Fusarium tested in this study formed biofilms, the F. solani strains were more efficient than
the others for all the studied parameters. The results of total biomass quantification and viable cell characterization
revealed the greater capacity of F. solani to form biofilms (Figures 1 & 2), suggesting that this species is more
virulent than the others. This finding is in accordance with the fact that this species is most frequently isolated
from invasive fusariosis [19]. Other studies have also described F. solani as the most virulent species, such as when F.
solani was injected intravenously and caused the death of all the animals tested, which other Fusarium species did
not [20].
Curiously, the values of XTT reduction assay in the present study decreased over time (Figure 2), suggesting a
reduction in the metabolic activity of the biofilms. It is important to point out that according to biofilm structure,
the fungal cells in sessile populations may display a poor physiological state, as confirmed by XTT-based assay [21].
Furthermore, Fusarium biofilms exhibit opposing kinetics (Figures 1 & 2), as metabolic activity was lowest at the
moment of peak biomass production and the inverse effect was also observed, corroborating the findings of other
studies [22,23]. This low metabolic activity could be due to the increased adsorption of compounds on the biofilm
matrix, meaning there is less contact between the tetrazolium salt and the cells of the mature biofilm [21–23]. It is
also important to emphasize that the association between these parameters (low activity and high biomass) is well
established in literature and is considered responsible for biofilm antifungal resistance, as fungi arranged in biofilms
are considered to be up to 1000-fold more resistant to antifungal agents than planktonic cells [21].
Regarding fungal biofilm formation, although most attention has been paid to the yeast pathogen Candida
albicans, it is known that many fungal species, including filamentous fungi, can form such structures [24,25]. Biofilm
morphology can vary according to the species involved and it has been found that even species from the same
genus can form biofilms with distinct arrangements [14]. The SEM results of the present study (Figure 4) have
shown that the Fusarium species used here can form biofilms with different morphologies and all the isolates were
able to organize dense growth, with a well-structured community constituted by large hyphae, sometimes with
conidiophores and conidia, suggesting a mature ecosystem.
When considering its ability to form biofilms, Peiqian et al. [13] reported that F. oxysporumwhen found in biofilms
was less susceptible to cold, heat, UV light and some fungicides than those grown in planktonic (free-living) cells. It
is well known that the capacity to form biofilms is related to higher resistance and difficulty in clinical treatment [5].
Considering that onychomycosis can be a portal of entry for invasive fusariosis, especially in immunocompromised
patients, the search for effective new topical treatments for onychomycosis caused by Fusarium spp. is highly
relevant. In addition, few antifungal agents are efficacious against fungal biofilms (echinocandins and liposomal
amphotericin B) and these drugs are not used for onychomycoses [21].
In this way, it is important to evaluate if a new antifungal option for planktonic cells exists, as PE also acts
against fungi organized in biofilms. Propolis is a resin that presents a number of medicinal properties [8], including
anti-inflammatory activity, which could potentiate a possible antifungal topical action. Furthermore, the capacity
of propolis to inhibit the biofilm formation of C. albicans has already been reported, along with the low cytotoxicity
in human cells with the same PE used in the present study [15,26]. However, the antifungal property of PE has not
yet been proved in biofilms formed by Fusarium species.
While microbiologists have historically tested the effect of drugs on planktonic cells, the present study evaluated
the action of PE on both planktonic cells and biofilm formation by Fusarium species. Initially, good results were
obtained for the MIC and MFC of PE against Fusariun spp. planktonic cells, which were 1093.75 μg ml-1, similar
to those described by Dota et al. [27] for Candida spp. The majority of isolates tested had MIC values between
550.3 and 1100.63 μg ml-1. Capoci et al. [15] also found similar values of MFC and MIC for Candida, proving
that propolis possesses a fungicide mechanism.
Next, the performance of this PE on biofilms formed by the Fusarium species was evaluated. The results
were exciting, as PE appears to be efficient, significantly reducing both the biomass and the number of viable
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cell parameters (p < 0.05) of the biofilms produced by all the evaluated isolates (Figures 5 & 6). In addition,
epifluorescence assay showed clearly that the number of cells of the biofilms formed by all the strains treated with
PE were reduced and the structure of the biofilm was lost, leaving only some damaged and isolated cells (Figure 7).
A possible limitation of this study was the absence of a comparison between the antibiofilm effects of propolis and
conventional antifungals. However, it should be pointed out that other works carried out by our group [15,26] have
shown propolis to be as or more efficient than other antifungal drugs. Moreover, Fusarium spp. are highly resistant
to azole antifungals which are not usually active against this fungus and terbinafine response varies according to
species [10]. We have not therefore included a conventional antifungal as a control.
In summary, it is known that biofilm-forming capacity is related to greater resistance and difficulty in treat-
ment [21]. PE is therefore promising as propolis can be found in its extract form in pharmacies, ready for topical use
in patients with onychomycosis, justifying the importance of the development of new treatment approaches with
the capacity to control fungal biofilms present in nails affected by Fusarium spp.
Conclusion
The results of the present study described the biofilm-forming capacity of three species of Fusarium isolated from
onychomycosis, with F. solani exhibiting the greatest such capacity, reinforcing that it is more virulent than the
other Fusarium species tested. We also demonstrated the antifungal and antibiofilm capacity of PE against clinical
isolates of F. solani, F. oxysporum and F. subglutinans. This reinforces the previous results and suggests that PE
could be an alternative option for the topical treatment of onychomycosis and avoid the possible dissemination of
this fungi of onychomycosis, since the most frequent species that cause human invasive fusariosis, F. solani and F.
oxysporum, are also the most frequent species that cause onychomycosis.
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Summary points
 Fusarium species isolated from onychomycosis form biofilm efficiently.
 Propolis presents potential antifungal activity.
 Propolis is a strong inhibitor of Fusarium spp. from onychomycosis.
 Propolis is able to reduce and destroy biofilms formed by Fusarium species.
 Propolis is a promising alternative to traditional antifungal therapy.
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